FDA trial oversight criticized

The HHS Office of Inspector General criticized FDA's oversight of clinical research in a report issued Friday. FDA has not corrected deficiencies in clinical trial oversight the OIG first identified in 1998, such as the lack of a database listing all clinical trials and Institutional Review Boards (IRBs) (See BioCentury, June 01, 1998). ...